Sfoglia per Autore
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease
2026 Scaravaglio, M; Ronzoni, L; Cristoferi, L; Miano, L; Nofit, E; Gerussi, A; Malinverno, F; Moretti, V; Torcianti, V; Caime, C; Cadamuro, M; D'Antiga, L; Invernizzi, P; Carbone, M; Valenti, L
Kupffer cell autophagy emerges as a central regulator of immune dysregulation in primary biliary cholangitis
2026 Sukubo, N; Caime, C; Gerussi, A; Invernizzi, P
IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury
2026 Zhou, X; Shao, S; Yang, D; Cheng, Z; Tanaka, T; Leung, P; Tsuneyama, K; Ansari, A; Ridgway, W; Invernizzi, P; Bowlus, C; Gershwin, M; Zhang, W
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial
2026 Cristoferi, L; D'Amato, D; Maino, C; Bernasconi, D; Dinelli, M; Malandrin, S; Facciotti, F; Festa, M; Gerussi, A; Rossi, E; Malinverno, F; Tettamanti, P; Cazzaniga, M; Corso, R; Ippolito, D; Galimberti, S; Invernizzi, P; Carbone, M
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross-Sectional Multicentre Study
2026 Uhlenbusch, N; Snijders, R; Mund, M; Janik, M; Milkiewicz, P; Lowe, B; Kroll, C; Raszeja-Wyszomirska, J; Gerussi, A; Bolis, F; Cristoferi, L; Invernizzi, P; Kovats, P; Papp, M; Gronbaek, L; Gronbaek, H; Tjwa, E; Aamann, L; Ytting, H; Ronca, V; Olsen, K; Oo, Y; Van Der Meer, A; Madaleno, J; Canhao, B; Engel, B; Campos-Murguia, A; Taubert, R; Koc, O; Kramer, M; Willemse, J; Lohse, A; Drenth, J; Gevers, T; Schramm, C
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis
2026 Abbas, N; Smith, R; Lytvyak, E; Scaravaglio, M; Halliday, N; Almahroos, A; Eden, N; Lloyd-Madden, D; Sharma, S; Ferguson, J; Dyson, J; Thorburn, D; Jones, D; Montano-Loza, A; Carbone, M; Invernizzi, P; Mells, G; Culver, E; Trivedi, P
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study
2026 Della Corte, C; D'Amato, D; Rocchetti, A; Martini, A; Morelli, M; Terracciani, F; Campigotto, M; Pugliese, N; Pieri, G; Simone, L; Malinverno, F; Degasperi, E; Reati, R; Federico, A; Gallo, R; Colarossi, C; Svegliati-Baroni, G; Morana, E; Rapetti, R; Surace, L; Arena, I; Perricone, G; Ferrari, G; Silano, M; Torreri, P; Invernizzi, P; Vespasiani-Gentilucci, U; Aghemo, A; Giannini, E; Durante-Mangoni, E; Missale, G; Saibeni, S; De Nucci, G; Manes, G; Vigano, M; Carbone, M
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial
2026 Trauner, M; Levy, C; Tanaka, A; Goodman, Z; Thorburn, D; Joshi, D; Salminen, K; Yimam, K; Isayama, H; Montano-Loza, A; Caldwell, S; Danta, M; Farkkila, M; Gallegos-Orozco, J; Gordon, S; Hinrichsen, H; Invernizzi, P; Vuppalanchi, R; Zhu, K; Xu, J; Liu, X; Lu, X; Crans, G; Bolbolan, S; Boyette, L; Alani, M; Barchuk, W; Watkins, T; Genovese, M; Bowlus, C
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis
2026 Wong, Y; Lam, L; Soret, P; Lemoinne, S; Hansen, B; Hirschfield, G; Gulamhusein, A; Lytvyak, E; Pares, A; Olivas, I; Londono, M; Rogriguez-Tajes, S; Eaton, J; Osman, K; Schramm, C; Sebode, M; Lohse, A; Dalekos, G; Gatselis, N; Nevens, F; Cazzagon, N; Zago, A; Russo, F; Floreani, A; Abbas, N; Trivedi, P; Thorburn, D; Saffioti, F; Barkai, L; Roccarina, D; Calvaruso, V; Fichera, A; Delamarre, A; Sobenko, N; Villamil, A; Medina-Morales, E; Bonder, A; Patwardhan, V; Rigamonti, C; Carbone, M; Invernizzi, P; Cristoferi, L; Van Der Meer, A; De Veer, R; Zigmond, E; Yehezkel, E; Kremer, A; Deibel, A; Bruns, T; Grosse, K; Wetten, A; Dyson, J; Jones, D; Levy, C; Tanaka, A; Dumortier, J; Pageaux, G; De Ledinghen, V; Carrat, F; Chazouilleres, O; Corpechot, C; Montano-Loza, A
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
2026 Invernizzi, P; Aghemo, A; Calvaruso, V; Lleo, A; Marzioni, M; Piscaglia, F; Rigamonti, C; Vespasiani Gentilucci, U; Brillanti, S; Carbone, M; Cazzagon, N; Lampertico, P
Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies
2025 Scaravaglio, M; Ronca, V; Carbone, M; Invernizzi, P
Primary sclerosing cholangitis: what is new in the therapeutic landscape
2025 Curto, A; Cristoferi, L; Carbone, M; Galli, A; Invernizzi, P
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database
2025 Loglio, A; Gardini, I; Conforti, M; Bartoli, M; Silvia, F; Coppola, C; Chessa, L; Svegliati-Baroni, G; Schiadà, L; Gentile, I; Pinchera, B; Brunetto, M; Colombatto, P; Aghemo, A; De Nicola, S; Toniutto, P; Giannini, E; Colecchia, A; Romagnoli, D; Sarmati, L; Ponziani, F; Morisco, F; Cammà, C; Cabibbo, G; Lampertico, P; Degasperi, E; Invernizzi, P; Ciaccio, A; Russo, F; Ippolito, A; Niro, G; Terreni, N; Nardone, G; Rocco, A; D'Antò, M; Sacerdoti, D; Ieluzzi, D; Ciancio, A; Pellicelli, A; Federico, A; Simone, L; Messina, V; Claar, E; Rosato, V; D'Offizi, G; Caraceni, P; Muratori, P; Giaccherini, C; Fagiuoli, S; Viganò, M
Neutrophils restricted contribution of CCRL2 genetic variants to COVID-19 severity
2025 Laffranchi, M; Paraboschi, E; Bianchetto-Aguilera, F; Tamassia, N; Gasperini, S; Gardiman, E; Pisera, A; Del Prete, A; Invernizzi, P; Gismondi, A; Mantovani, A; Cassatella, M; Asselta, R; Sozzani, S
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
2025 Ciardullo, S; Dodesini, A; Muraca, E; Invernizzi, P; Trevisan, R; Perseghin, G
Hepatic arterioportal fistula after biopsy conditioning portal hypertension: first case in primary biliary cholangitis and a systematic literature review
2025 Gallo, C; Invernizzi, P
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model
2025 Cazzaniga, G; L'Imperio, V; Bonoldi, E; Londoño, M; Madaleno, J; Cipriano, A; Gevers, T; Samarska, I; Koc, Ö; Villamil, A; Sanchez, M; Calvaruso, V; Quattrocchi, A; Cabibi, D; Engel, B; Malinverno, F; Merelli, E; Cristoferi, L; Carbone, M; Pagni, F; Invernizzi, P; Gerussi, A
Primary Biliary Cholangitis
2025 Leung, P; Shao, T; Wang, L; Tsuneyama, K; Invernizzi, P; Timilsina, S; Gershwin, M
Primary Sclerosing Cholangitis
2025 Hsu, R; Leung, P; Invernizzi, P; Gershwin, M
The effects of elafibranor in people with primary biliary cholangitis: a plain language summary
2025 Kowdley, K; Bowlus, C; Levy, C; Akarca, U; Alvares-da-Silva, M; Andreone, P; Arrese, M; Francque, S; Heneghan, M; Invernizzi, P; Jones, D; Lawitz, E; Mayo, M; Swain, M; Vargas, V; Vierling, J; Villamil, A; Addy, C; Dietrich, J; Mazain, S; Taddé, B; Miller, B; Shu, J; Zein, C; Roberts, C; Wright, G; Schattenberg, J
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile